JP2002503687A - 内耳の疾患又は機能障害の治療方法 - Google Patents

内耳の疾患又は機能障害の治療方法

Info

Publication number
JP2002503687A
JP2002503687A JP2000532105A JP2000532105A JP2002503687A JP 2002503687 A JP2002503687 A JP 2002503687A JP 2000532105 A JP2000532105 A JP 2000532105A JP 2000532105 A JP2000532105 A JP 2000532105A JP 2002503687 A JP2002503687 A JP 2002503687A
Authority
JP
Japan
Prior art keywords
inner ear
active ingredient
cells
use according
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000532105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002503687A5 (https=
Inventor
ヒューベルト ロエヴェンハイム
Original Assignee
オトゲネ アクチェン ゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オトゲネ アクチェン ゲゼルシャフト filed Critical オトゲネ アクチェン ゲゼルシャフト
Publication of JP2002503687A publication Critical patent/JP2002503687A/ja
Publication of JP2002503687A5 publication Critical patent/JP2002503687A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2000532105A 1998-02-23 1999-02-23 内耳の疾患又は機能障害の治療方法 Pending JP2002503687A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19807426.3 1998-02-23
DE19807426A DE19807426A1 (de) 1998-02-23 1998-02-23 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
PCT/EP1999/001153 WO1999042088A2 (de) 1998-02-23 1999-02-23 Verfahren zur behandlung von erkrankungen oder störungen des innenohrs

Publications (2)

Publication Number Publication Date
JP2002503687A true JP2002503687A (ja) 2002-02-05
JP2002503687A5 JP2002503687A5 (https=) 2006-04-13

Family

ID=7858563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000532105A Pending JP2002503687A (ja) 1998-02-23 1999-02-23 内耳の疾患又は機能障害の治療方法

Country Status (11)

Country Link
US (1) US7087581B1 (https=)
EP (1) EP1056467B1 (https=)
JP (1) JP2002503687A (https=)
AT (1) ATE250936T1 (https=)
AU (1) AU763868B2 (https=)
CA (1) CA2320717C (https=)
DE (2) DE19807426A1 (https=)
DK (1) DK1056467T3 (https=)
ES (1) ES2211055T3 (https=)
PT (1) PT1056467E (https=)
WO (1) WO1999042088A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390482B2 (en) 2002-10-02 2008-06-24 Anges Mg, Inc. Drug for auditory dysfunction
JP2013518917A (ja) * 2010-02-08 2013-05-23 イーエムシー マイクロコレクションズ ゲーエムベーハー 感覚器官及び有糸分裂後組織のための再生促進物質としての新規なアミノアルキルオキサゾール及びアミノアルキルチアゾールカルボン酸アミド

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1471926E (pt) 1999-06-01 2011-03-11 Baylor College Medicine Composições e métodos para a utilização terapêutica de uma sequência associada a atonal
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
KR100896489B1 (ko) * 2000-07-11 2009-05-08 사운드 파마슈티칼스 인코퍼레이티드 내이에서 세포 재생 및 분화의 자극
DE60323876D1 (de) * 2002-12-17 2008-11-13 Centre Nat Rech Scient Verwendung von purinderivaten zur induktion der differenzierung überzähliger haarzellen und deiter-zellen im entwickelnden corti-organ zur behandlung von taubheit
JP5524189B2 (ja) 2008-06-06 2014-06-18 クォーク ファーマシューティカルズ インコーポレーティッド 耳障害治療のための組成物および方法
RU2480195C1 (ru) * 2011-11-02 2013-04-27 Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") Способ лечения заболеваний внутреннего уха
EP2802657B1 (en) 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
WO2013134022A1 (en) * 2012-03-05 2013-09-12 Wake Forest University Health Sciences Regeneration of inner ear cells
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
JP2000505781A (ja) * 1995-11-13 2000-05-16 ケンブリッジ ニューロサイエンス インコーポレイテッド 非視覚性感覚上皮の疾患の治療方法
US5962224A (en) 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
AU3591597A (en) 1996-06-28 1998-01-21 Regents Of The University Of California, The Transformation and genetherapy of cells of the inner ear
WO1998013048A1 (en) * 1996-09-27 1998-04-02 Trustees Of The University Of Pennsylvania Novel methods for inducing proliferation in auditory receptor epithelium
US6043221A (en) 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6009017176, Ｓｔ． Ｃｒｏｉｘ， Ｂ． ｅｔ ａｌ．, Ｎａｔｕｒｅ Ｍｅｄｉｃｉｎｅ, 1996, Ｖｏｌ．２， Ｎｏ．１１ *
JPN6009017178, Ｃｏａｔｓ Ｓ． ｅｔ ａｌ．, Ｓｃｉｅｎｃｅ, 1996, Ｖｏｌ．２７２（５２６３）, ｐｐ．８７７−８８０ *
JPN6009017182, Ｕｍｅｍｏｔｏ， Ｍ． ｅｔ ａｌ．, Ｃｅｌｌ ａｎｄ Ｔｉｓｓｕｅ Ｒｅｓｅａｒｃｈ, 1995, Ｖｏｌ．２８１， Ｎｏ．３, ｐｐ．４３５−４４３ *
JPN6009017185, Ｃｈａｒｄｉｎ， Ｓ． ｅｔ ａｌ．, Ｓｃｉｅｎｃｅ, 1995, Ｖｏｌ．２６７, ｐｐ．７０７−７１１ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390482B2 (en) 2002-10-02 2008-06-24 Anges Mg, Inc. Drug for auditory dysfunction
JP2013518917A (ja) * 2010-02-08 2013-05-23 イーエムシー マイクロコレクションズ ゲーエムベーハー 感覚器官及び有糸分裂後組織のための再生促進物質としての新規なアミノアルキルオキサゾール及びアミノアルキルチアゾールカルボン酸アミド

Also Published As

Publication number Publication date
DK1056467T3 (da) 2004-02-09
DE19807426A1 (de) 1999-10-14
EP1056467A2 (de) 2000-12-06
ES2211055T3 (es) 2004-07-01
CA2320717C (en) 2009-03-24
DE59907195D1 (de) 2003-11-06
WO1999042088A3 (de) 2000-03-02
AU2928199A (en) 1999-09-06
WO1999042088A2 (de) 1999-08-26
US7087581B1 (en) 2006-08-08
ATE250936T1 (de) 2003-10-15
CA2320717A1 (en) 1999-08-26
PT1056467E (pt) 2004-02-27
EP1056467B1 (de) 2003-10-01
AU763868B2 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
Liao et al. Intranasal delivery of lincRNA-Cox2 siRNA loaded extracellular vesicles decreases lipopolysaccharide-induced microglial proliferation in mice
Leake et al. Brain‐derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats
Fukui et al. BDNF gene therapy induces auditory nerve survival and fiber sprouting in deaf Pou4f3 mutant mice
US10330671B2 (en) Modulation of synaptic maintenance
JP7461071B2 (ja) クロマチンアクセシビリティ及び心筋細胞の再生を誘発する、Ｈｉｐｐｏエフェクターである優性活性Ｙａｐ
JP2018076332A (ja) （３ａＲ）−１，３ａ，８−トリメチル−１，２，３，３ａ，８，８ａ−ヘキサヒドロピロロ［２，３−ｂ］インドール−５−イルフェニルカルバメートの有効量およびその使用方法
Arribat et al. Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease
JP2002503687A (ja) 内耳の疾患又は機能障害の治療方法
JP2001517947A (ja) ポリヌクレオチドの脳内注入による慢性脳炎モデル
Akil et al. Virally mediated overexpression of glial-derived neurotrophic factor elicits age-and dose-dependent neuronal toxicity and hearing loss
CN110041408A (zh) 一种小分子多肽及其在制备防治帕金森综合症药物中的应用
Holley Application of new biological approaches to stimulate sensory repair and protection
CA3062744A1 (en) Neurotrophins for use in the treatment of hearing loss
DE602004003348T2 (de) Pten-hemmer oder maxi-k-kanalöffner
Kempfle et al. A novel small molecule neurotrophin-3 analogue promotes inner ear neurite outgrowth and synaptogenesis in vitro
JP6601882B2 (ja) 感音性難聴の治療用のステロール誘導体の利用及び対応する組成物
CA3072175A1 (en) Photoreceptor gene modulator photoregulin 3 for treatment of retinal disease
Chen et al. Efficiency of PGK1 proteins delivered to the brain via a liposomal system through intranasal route administration for the treatment of spinocerebellar ataxia type 3
EP2534139A1 (de) Neue aminoalkyl-oxazol- und aminoalkyl-thiazolcarbonsäureamide als regenerationsfördernde substanzen für sinnesorgane und postmitotische gewebe
Keine et al. Cellular and Synaptic Mechanisms in the Auditory System in Health and Diseas
Espina Cortes Uncovering new therapeutic strategies for motor and cognitive deficits in Huntington's Disease
EP3566700A1 (en) Ambroxol for dna damage repair disease therapies
Caelers et al. Nogo in the mammalian cochlea
Galindo The effect of neurotrophic factors on spiral ganglion neurons
HK1091409B (en) Pten inhibitor or maxi-k channels opener

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20041018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060221

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090414

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090709

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090716

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090813

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100720

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110105